Anika Therapeutics (ANIK) Tops Q2 EPS by 32c
Tweet
Share
E-mailGet Alerts ANIK Hot Sheet
Price: $20.48 -1.96%
EPS Growth %: -25.0%
Financial Fact:
Licensing, milestone and contract revenue: 6K
Today's EPS Names:
OCCI, ALZN, ASPU, More
EPS Growth %: -25.0%
Financial Fact:
Licensing, milestone and contract revenue: 6K
Today's EPS Names:
OCCI, ALZN, ASPU, More
Join SI Premium – FREE
Anika Therapeutics (NASDAQ: ANIK) reported Q2 EPS of $0.76, $0.32 better than the analyst estimate of $0.44. Revenue for the quarter came in at $33.46 million versus the consensus estimate of $27.2 million.
For earnings history and earnings-related data on Anika Therapeutics (ANIK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Paychex (PAYX) Tops Q1 EPS by 2c
- KB Home (KBH) Tops Q3 EPS by 16c
- Cracker Barrel (CBRL) Tops Q4 EPS by 89c, Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
